Efficacy of Human Placental Graft in Diabetic Foot Ulcers
A Clinical Investigation Into the Efficacy of Full-thickness Human Placental Graft (Revita) in Diabetic Foot Ulcers
Sponsor: StimLabs
Terminated
Low enrollment.
Other terminated trials from StimLabs
More terminations from StimLabs
Other Diabetic Foot trials with similar outcome
Listed as NCT03708029, this NA trial focuses on Diabetic Foot and remains terminated or withdrawn. Sponsored by StimLabs, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Aug 2024 — Sep 2024 [monthly]
Terminated NA
Status: Unknown → Terminated
-
Jul 2024 — Aug 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Dec 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Dec 2018 — Dec 2020 [monthly]
Recruiting NA
-
Nov 2018 — Dec 2018 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- StimLabs
For direct contact, visit the study record on ClinicalTrials.gov .